Redona Therapeutics, Inc. — Form D/A
Redona Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2023-07-31. The offering totals $76.9M, of which $60.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-31
- Form: D/A
- Accession: 0001751998-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $76.9M
- Amount sold: $60.8M
- Remaining: $16.1M
- Investors: 11
- Date of first sale: 2018-08-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320722
Issuer
- Name: Redona Therapeutics, Inc.
- CIK: 0001751998
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 490 ARSENAL WAY, WATERTOWN, MA, 02472
- Phone: 617-603-6060
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Christine Brennan | Director | Watertown, MA |
| Luke Evnin | Director | Watertown, MA |
| Henrijette Richter | Director | Paris, I0 |
| Kazumi Shiosaki | Director | Watertown, MA |
| Michal Silverberg | Director | Watertown, MA |
| Kazumi Shiosaki | Executive Officer | Watertown, MA |
| Briggs Morrison | Director | Cambridge, MA |
| Marian Nakada | Director | Ann Arbor, MI |
| Carolyn Ng | Director | Cambridge, MA |
Other filings by this issuer (3)
More